ABOUT US

关于我们

INTERNATIONAL COOPERATION

  • 2012

    Guangzhou doublink biological cooperation with Masala company of Canada E10A clinical program, a $17 million gain stage payments

  • 2013

    E10A project to obtain approval of the United States clinical III

  • 2015

    Access to Japan's largest CRO company, Japan EPS Yi Xin Co., Ltd. 20 million investment.

  • 2015

    Okayama University E10E project.